Assessment of Continuous Positive Airway Pressure Therapy on Idiopathic Pulmonary Fibrosis (ACT-IPF)
Study to Understand Whether Treating Sleep Apnea May Reduce Lung Injury in People with Pulmonary Fibrosis
Sponsor: National Heart, Lung, and Blood Institute - NHLBI
Enrolling: Male and Female Patients
Study Length: 6 Months
IRB Number: AAAR6902
U.S. Govt. ID: NCT03901534
Contact: Sanja Jelic: 212-342-0256 /
Additional Study Information: The purpose of this research study is to help us understand whether blood markers of lung injury are worse in adult patients with interstitial lung disease and obstructive sleep apnea compared with patients with interstitial lung disease who do not have obstructive sleep apnea.
This study is closed
Sanja Jelic, MD
Do You Qualify?
Have you been diagnosed with idiopathic pulmonary fibrosis (IPF)? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Sanja Jelic